Coherus Biosciences | CHRS - Stock


Coherus Biosciences reported $3.17M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Akebia Therapeutics USD 15.61M 3.03M Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amarin USD 184.7M 13.46M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Fujifilm JPY 600.12B 1.55B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Merck USD 6.44B 157M Sep/2025
Myriad Genetics USD 31.6M 2.9M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025
Zoetis USD 2.43B 35M Dec/2025